Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of dopamine receptor agonists and antagonists on release of dopamine in the rabbit caudate nucleus in vitro.

× No keyword cloud information.

24 in total

1. Comparison of the effects of neuroleptic drugs on pre- and postsynaptic dopaminergic mechanisms in the rat striatum.

Authors: L L Iversen; M A Rogawski; R J Miller
Journal: Mol Pharmacol Date: 1976-03 Impact factor: 4.436

Review 2. Bromocriptine.

Authors: D Parkes
Journal: Adv Drug Res Date: 1977

Review 3. Neurotransmitter uptake: a tool in identifying neurotransmitter-specific pathways.

Authors: M J Kuhar
Journal: Life Sci Date: 1973-12-16 Impact factor: 5.037

4. The fluorometric assay of catecholamines and related compounds: improvements and extensions to the hydroxyindole technique.

Authors: R Laverty; K M Taylor
Journal: Anal Biochem Date: 1968-02 Impact factor: 3.365

5. Preferential metabolism of (-) 3 H-norepinephrine through the deaminated glycol in the rat vas deferens.

Authors: K H Graffe; F J Stefano; S Z Langer
Journal: Biochem Pharmacol Date: 1973-05-15 Impact factor: 5.858

6. Differential effects of three dopamine agonists: apomorphine, bromocriptine and lergotrile.

Authors: E K Silbergeld; R F Pfeiffer
Journal: J Neurochem Date: 1977-06 Impact factor: 5.372

7. Interaction of ergot drugs with central monoamine systems. Evidence for a high potential in the treatment of mental and neurological disorders.

Authors: K Fuxe; B B Fredholm; L F Agnati; S O Ogren; B J Everitt; G Jonsson; J A Gustafsson
Journal: Pharmacology Date: 1978 Impact factor: 2.547

8. Dopamine- -hydroxylase in the rat brain: developmental characteristics.

Authors: J T Coyle; J Axelrod
Journal: J Neurochem Date: 1972-02 Impact factor: 5.372

9. Brain dopamine- -hydroxylase: regional distribution and effects of lesions and 6-hydroxy-dopamine on activity.

Authors: D J Reis; P B Molinoff
Journal: J Neurochem Date: 1972-01 Impact factor: 5.372

10. Involvement of cholinergic presynaptic receptors of nicotinic and muscarinic types in the control of the spontaneous release of dopamine from striatal dopaminergic terminals in the rat.

Authors: M F Giorguieff; M L Le Floc'h; J Glowinski; M J Besson
Journal: J Pharmacol Exp Ther Date: 1977-03 Impact factor: 4.030

53 in total

1. Presynaptic regulation of the electrically evoked release of endogenous dopamine from the isolated neurointermediate lobe or isolated neural lobe of the rat pituitary gland in vitro.

Authors: K Racké; A Grosshans; S Sirrenberg; K Ziegler
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1988-05 Impact factor: 3.000

2. Transmitter release patterns of noradrenergic, dopaminergic and cholinergic axons in rabbit brain slices during short pulse trains, and the operation of presynaptic autoreceptors.

Authors: A Mayer; N Limberger; K Starke
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1988-12 Impact factor: 3.000

10. Presynaptic opioid receptors on dopaminergic nerves in the rabbit caudate nucleus: coupling to pertussis toxin-sensitive G-proteins and interaction with D2 autoreceptors?

Authors: R Jackisch; H Hotz; C Allgaier; G Hertting
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1994-03 Impact factor: 3.000

Effect of dopamine receptor agonists and antagonists on release of dopamine in the rabbit caudate nucleus in vitro.

1. Comparison of the effects of neuroleptic drugs on pre- and postsynaptic dopaminergic mechanisms in the rat striatum.

Review 2. Bromocriptine.

Review 3. Neurotransmitter uptake: a tool in identifying neurotransmitter-specific pathways.

4. The fluorometric assay of catecholamines and related compounds: improvements and extensions to the hydroxyindole technique.

5. Preferential metabolism of (-) 3 H-norepinephrine through the deaminated glycol in the rat vas deferens.

6. Differential effects of three dopamine agonists: apomorphine, bromocriptine and lergotrile.

7. Interaction of ergot drugs with central monoamine systems. Evidence for a high potential in the treatment of mental and neurological disorders.

8. Dopamine- -hydroxylase in the rat brain: developmental characteristics.

9. Brain dopamine- -hydroxylase: regional distribution and effects of lesions and 6-hydroxy-dopamine on activity.

10. Involvement of cholinergic presynaptic receptors of nicotinic and muscarinic types in the control of the spontaneous release of dopamine from striatal dopaminergic terminals in the rat.

1. Presynaptic regulation of the electrically evoked release of endogenous dopamine from the isolated neurointermediate lobe or isolated neural lobe of the rat pituitary gland in vitro.

2. Transmitter release patterns of noradrenergic, dopaminergic and cholinergic axons in rabbit brain slices during short pulse trains, and the operation of presynaptic autoreceptors.

Review 3. Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of the evidence.

4. Presynaptic alpha 2A-adrenoceptors inhibit the release of endogenous dopamine in rabbit caudate nucleus slices.

5. Pathways of dopamine metabolism in the rabbit caudate nucleus in vitro.

6. Amphetamine induced release of endogenous dopamine in vitro is not reduced following pretreatment with reserpine.

7. Behavioral responses to apomorphine and amphetamine in differentially housed mice.

8. Release of endogenous dopamine from rat isolated striatum: effect of clorgyline and (-)-deprenyl.

9. Effects of various experimental manipulations on neostriatal acetylcholine and dopamine release.

10. Presynaptic opioid receptors on dopaminergic nerves in the rabbit caudate nucleus: coupling to pertussis toxin-sensitive G-proteins and interaction with D2 autoreceptors?